We are live on
!
Find out more
TI
Telemetry Investments Portfolio holdings
AUM
$63.3M
Turnover
53.18%
1-Year Est. Return
0.06%
This Fund
S&P 500
This Quarter
Est. Return
-3.87%
1 Year Est. Return
+0.06%
3 Year Est. Return
+77.42%
5 Year Est. Return
+156.79%
10 Year Est. Return
–
AUM
$34.7M
AUM Growth
-$94.8M
(-73%)
Cap. Flow
-$17.4M
Cap. Flow
% of AUM
-50.11%
Top 10 Holdings %
Top 10 Hldgs %
53.9%
Holding
92
New
11
Increased
15
Reduced
20
Closed
39
Avg Time Held Equity + Options
0.8
years
Top 10 Avg Time Held Equity + Options
0.3
years
Top 20 Avg Time Held Equity + Options
0.3
years
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.91M |
| 2 |
CELG
Celgene Corp
CELG
|
+$1.69M |
| 3 |
MDSO
Medidata Solutions, Inc.
MDSO
|
+$612K |
| 4 |
Dermira, Inc.
DERM
|
+$488K |
| 5 |
VRAY
ViewRay, Inc.
VRAY
|
+$439K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
+$2.78M |
| 2 |
RHT
Red Hat Inc
RHT
|
+$2.35M |
| 3 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
+$1.72M |
| 4 |
OAK
OAKTREE CAPITAL GROUP, LLC
OAK
|
+$1.56M |
| 5 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$1.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 56.98% |
| 2 | Miscellaneous | 16.1% |
| 3 | Materials | 7.31% |
| 4 | Technology | 5.39% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $2.38M | 6.87% |
24,000
+17,800
| +287% | +$1.69M |
2019 Q2
1 quarter
|
|
|
KDMN
2
DELISTED
Kadmon Holdings, Inc.
KDMN
| $2.25M | 6.48% |
891,500
-1,121,748
| -56% | -$2.78M |
2016 Q4
11 quarters
|
|
|
EIGR
3
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $2.23M | 6.42% |
7,234
-5,301
| -42% | -$1.72M |
2018 Q2
5 quarters
|
|
4
Xtant Medical Holdings
XTNT
$44.7M
| $2.19M | 6.32% |
771,536
-10,818
| -1% | -$30.1K |
2018 Q3
4 quarters
|
|
|
WCG
5
DELISTED
Wellcare Health Plans, Inc.
WCG
| $2.1M | 6.05% |
8,100
+600
| +8% | +$166K |
2019 Q2
1 quarter
|
|
|
AGN
6
DELISTED
Allergan plc
AGN
| $1.97M | 5.68% |
+11,700
| New | +$1.91M |
2019 Q3
0 quarters
|
|
|
VSM
7
DELISTED
Versum Materials, Inc.
VSM
| $1.93M | 5.57% |
36,500
-4,500
| -11% | -$234K |
2019 Q2
1 quarter
|
|
8
PUT
Bausch Health
BHC
$2.2B
| $1.43M | 4.11% |
65,200
-14,800
| -19% | -$339K |
2018 Q4
3 quarters
|
|
|
ZSAN
9
DELISTED
Zosano Pharma Corporation
ZSAN
| $1.13M | 3.27% |
20,753
+2,638
| +15% | +$237K |
2018 Q1
6 quarters
|
|
|
WPX
10
CALL
DELISTED
WPX Energy, Inc.
WPX
| $1.06M | 3.05% |
100,000
| – | – |
2019 Q2
1 quarter
|
|
|
MDSO
11
DELISTED
Medidata Solutions, Inc.
MDSO
| $897K | 2.59% |
9,800
+6,700
| +216% | +$612K |
2019 Q2
1 quarter
|
|
|
12
DELISTED
Dermira, Inc.
DERM
| $882K | 2.54% |
138,000
+58,500
| +74% | +$488K |
2019 Q2
1 quarter
|
|
13
DELISTED
Affimed
AFMD
| $825K | 2.38% |
28,067
-40,337
| -59% | -$1.2M |
2015 Q2
17 quarters
|
|
|
MLNX
14
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $689K | 1.99% |
6,289
+644
| +11% | +$71.1K |
2019 Q2
1 quarter
|
|
15
Globalstar
GSAT
$10.7B
| $657K | 1.89% |
105,936
+3,737
| +4% | +$23.5K |
2017 Q3
8 quarters
|
|
16
SPDR Gold Trust
GLD
$139B
| $625K | 1.8% |
4,500
-4,300
| -49% | -$598K |
2017 Q3
8 quarters
|
|
|
BPL
17
DELISTED
Buckeye Partners, L.P.
BPL
| $577K | 1.66% |
14,042
-12,958
| -48% | -$534K |
2019 Q2
1 quarter
|
|
18
DELISTED
Sprint Corporation
S
| $457K | 1.32% |
74,000
-18,500
| -20% | -$127K |
2018 Q4
3 quarters
|
|
|
VRAY
19
DELISTED
ViewRay, Inc.
VRAY
| $440K | 1.27% |
151,557
+74,057
| +96% | +$439K |
2017 Q2
9 quarters
|
|
20
Rigel Pharmaceuticals
RIGL
$875M
| $425K | 1.23% |
22,750
-650
| -3% | -$13.4K |
2014 Q4
19 quarters
|
|
|
STML
21
DELISTED
Stemline Therapeutics, Inc.
STML
| $416K | 1.2% |
40,000
+6,000
| +18% | +$78.5K |
2018 Q4
3 quarters
|
|
22
DELISTED
El Paso Electric Company
EE
| $402K | 1.16% |
6,000
-7,000
| -54% | -$465K |
2019 Q2
1 quarter
|
|
|
ACIA
23
DELISTED
Acacia Communications Inc
ACIA
| $392K | 1.13% |
+6,000
| New | +$380K |
2019 Q3
0 quarters
|
|
24
Cigna
CI
$76.5B
| $350K | 1.01% |
2,305
+155
| +7% | +$25.2K |
2018 Q4
3 quarters
|
|
|
CBLK
25
DELISTED
Carbon Black, Inc. Common Stock
CBLK
| $338K | 0.97% |
+13,000
| New | +$287K |
2019 Q3
0 quarters
|
|
Similar funds
SF
CAM
SCFS
LCH
SGMPI
HJMC
AI
DFAM
Telemetry Investments's Q3 2019 Portfolio in Review
As of Q3 2019, Telemetry Investments held 92 positions worth $34.7M, down 73% from $129M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Telemetry Investments withdrew a net $17.4M in Q3 2019, closing 39 positions and reducing 20 holdings. Its most notable exit was Red Hat Inc, an estimated $2.35M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Materials.
Against the trend, Telemetry Investments opened a new position in Allergan plc worth $1.97M.
- Telemetry Investments's largest Q3 2019 buy was Allergan plc: 11,700 shares worth $1.97M.
- Telemetry Investments added most to Celgene Corp in Q3 2019, an estimated $1.69M increase.
- Telemetry Investments's biggest Q3 2019 reduction was Kadmon Holdings, Inc., cutting an estimated $2.78M.
- Telemetry Investments fully exited Red Hat Inc in Q3 2019, selling an estimated $2.35M.
- Telemetry Investments's ten largest holdings make up 54% of its $34.7M portfolio in Q3 2019.
- Telemetry Investments opened 11 new positions and closed 39 in Q3 2019.
- Telemetry Investments's portfolio value fell 73% quarter-over-quarter to $34.7M.
Based on Telemetry Investments's 13F filing for Q3 2019, filed 14 Nov 2019.